Keryx Biopharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now up 6% in the past one-month time frame.

The company has seen three negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Keryx Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Keryx Biopharmaceuticals, Inc. Price

Keryx Biopharmaceuticals, Inc. Price | Keryx Biopharmaceuticals, Inc. Quote

A better-ranked stock in the Medical sector is Axovant Sciences Ltd. (AXON Quick QuoteAXON - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is KERX going up? Or down? Predict to see what others think: Up or Down.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>